Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Upslope Capital Management Exited West Pharmaceutical (WST) for Better Opportunities

Upslope Capital Management, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Upslope aims to provide attractive, equity-like returns while reducing market risk and keeping low correlation with traditional equity strategies. The fourth quarter marked a strong end to an exceptional year for the firm. The Fund delivered strong results with reduced downside risk. The Fund returned +2.0% (net) in Q4 compared to +1.6% for both the S&P Midcap 400 ETF (MDY) and HFRX Equity Hedge Index. For the year 2025, the Fund...